News
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...
Merck is looking to strengthen its respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer ...
3d
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...
This $117 billion Australian success story asked the US government to give it a break on tariffs, but is now waiting to see ...
The drug company has spent millions lobbying in DC. Now it's turning to the president's realty firm for help offloading a $12 ...
Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of ...
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
3d
GlobalData on MSNTrump’s 200% tariff threat could send shockwaves through pharma supply chainsDespite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results